174 related articles for article (PubMed ID: 9249232)
21. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
22. Single dose captopril as a diagnostic test for primary aldosteronism.
Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
[TBL] [Abstract][Full Text] [Related]
23. [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)].
Shigetomi S; Fukuchi S; Haruyama K; Yamazaki M
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):184-98. PubMed ID: 6212269
[TBL] [Abstract][Full Text] [Related]
24. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
[TBL] [Abstract][Full Text] [Related]
25. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
26. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
[TBL] [Abstract][Full Text] [Related]
27. Night-day variations of renin-activity in primary aldosteronism.
Siebenschein R; Vetter W; Leinert R; Siegenthaler W; Vetter H
Horm Metab Res; 1979 Oct; 11(10):570-3. PubMed ID: 574849
[TBL] [Abstract][Full Text] [Related]
28. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
Kater CE; Biglieri EG
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin-aldosterone system in arterial hypertension.
Horký K; Gregorová I
Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
[TBL] [Abstract][Full Text] [Related]
30. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Schwartz GL; Turner ST
Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
[TBL] [Abstract][Full Text] [Related]
31. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
32. Clinical and pathological diversity of primary aldosteronism, including a new familial variety.
Gordon RD; Stowasser M; Tunny TJ; Klemm SA; Finn WL; Krek AL
Clin Exp Pharmacol Physiol; 1991 May; 18(5):283-6. PubMed ID: 2065471
[TBL] [Abstract][Full Text] [Related]
33. Effect of naloxone on the adrenal cortex in primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
[TBL] [Abstract][Full Text] [Related]
34. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
[TBL] [Abstract][Full Text] [Related]
35. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
Zadik Z; Levin PA; Hamilton BP; Kowarski AA
Hypertension; 1986 Apr; 8(4):285-9. PubMed ID: 3514448
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
37. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
[TBL] [Abstract][Full Text] [Related]
38. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling.
Omura M; Sasano H; Fujiwara T; Yamaguchi K; Nishikawa T
Metabolism; 2002 Mar; 51(3):350-5. PubMed ID: 11887172
[TBL] [Abstract][Full Text] [Related]
39. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
[TBL] [Abstract][Full Text] [Related]
40. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
